Table 1.
Key Table
Summary of the Relative Importance of the Different Drug Properties for the Different Use Scenariosa
Property | Refs | |||||
---|---|---|---|---|---|---|
Clearance of Blood-Stage Parasites | Duration of Prophylaxis | Enhanced Gametocytocidal Activityb | Mosquitocidal Activity | Hypnozoite Activityc | ||
First-line treatment | +++ | ++ | + | + | ++ | 23, 25, 42, 45, 46, 49, 50, 61 |
Chemoprevention: children | +++ | +++ | ?? | ?? | ?? | 44, 52, 89, 90 |
Chemoprevention: pregnant women | +++ | +++ | ?? | ?? | ?? | 56, 57 |
MDA: elimination | ++ | ++ | + | +++ | +++ | 36, 37, 38, 39, 42, 60 |
MDA: emergencies | ++ | ++ | + | ?? | ?? | 62, 63 |
The rankings are based on a review of the modelling literature with the key references shown in the final column. +++ = very important; ++ = moderately important; + = limited importance; ?? = further research required.
Enhanced gametocytocidal activity refers to that greater than current ACTs.
Relevant to Plasmodium vivax only.